Medtronic‘s (NYSE:MDT) Canada subsidiary said today that it won a license from Health Canada for its MiniMed 670G insulin pump system.
The insulin pump system is the first device in Canada that stabilizes glucose levels by automatically adjusting basal insulin delivery according to a user’s real-time needs, the medtech titan touted.
Get the full story at our sister site, Drug Delivery Business News.
The post Canada clears Medtronic’s MiniMed 670G insulin pump appeared first on MassDevice.